Table 2.
Comparison of the laboratory test results, waist circumference, BMI, blood pressure values and metabolic syndrome rates between the study and the control groups
| Variables | Study group (n = 155) |
Control group (n = 155) |
p-Value |
|---|---|---|---|
| FPG (mg/dL) (mean ± SD) | 93 ± 20.82 | 87.78 ± 11.40 | 0.013 |
| HDL cholesterol (mg/dL) (mean ± SD) | 50.08 ± 10.90 | 50.13 ± 12.37 | 0.970 |
| LDL cholesterol (mg/dL) (mean ± SD) | 134.09 ± 31.11 | 113.56 ± 24.11 | 0.031 |
| TG (mg/dL) (mean ± SD) | 127.00 ± 75.90 | 123.45 ± 71.85 | 0.630 |
| CRP (mg/L) (mean ± SD) | 0.36 ± 0.24 | 0.26 ± 0.14 | 0.05 |
| Vitamin B12 (pg/mL) (mean ± SD) | 245.12 ± 100.86 | 245.91 ± 130.00 | 0.953 |
| Vitamin B12 deficiency rate, n (%) | 62 (41.1%) | 64 (42.1%) | 0.854 |
| Vitamin B12 replacement rate, n (%) | 25 (16.1%) | 12 (7.7%) | 0.036 |
| Waist circumference (cm) (mean ± SD) | 94.20 ± 13.06 | 91.72 ± 11.85 | 0.08 |
| BMI (kg/m2) (mean ± SD) | 26.28 ± 4.71 | 25.35 ± 3.71 | 0.054 |
| Systolic blood pressure (mmHg) (mean ± SD) | 115 ± 15.50 | 109.29 ± 14.67 | 0.02 |
| Diastolic Blood pressure (mmHg) (mean ± SD) | 74.83 ± 10.07 | 71.38 ± 9.17 | 0.05 |
| Metabolic syndrome rate, n (%) | |||
| NCEP-ATPIII criteria | 58 (37.4%) | 30 (19.4%) | <0.001 |
| IDF criteria | 62 (40%) | 41 (26.5%) | 0.011 |
FPG, Fasting Plasma Glucose; HDL, High-Density Lipoprotein; LDL, Low-Density Lipoprotein; TG, Triglyceride; CRP, C-Reactive Protein; BMI, Body-Mass Index, NCEP-ATPIII, National Cholesterol Education Program Adult Treatment Panel III; IDF, The International Diabetes Federation.